Long-term follow-up of the original interferon-β1b trial in multiple sclerosis: Design and lessons from a 16-year observational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term follow-up of the original interferon-β1b trial in multiple sclerosis: Design and lessons from a 16-year observational study

Published:2009-08 Issue:8 Volume:31 Page:1724-1736
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Ebers George C.,Reder Anthony T.,Traboulsee Anthony,Li David,Langdon Dawn,Goodin Douglas S.,Wolf Christian,Beckmann Karola,Konieczny Andreas

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference27 articles.

1. Multiple Sclerosis,1998

2. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability;Weinshenker;Brain.,1989

3. Prediction of outcome in multiple sclerosis based on multivariate models;Runmarker;J Neurol.,1994

4. Disability as an outcome in MS clinical trials;Ebers;Neurology,2008

5. MRI as an outcome in multiple sclerosis clinical trials;Daumer;Neurology,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis;Pharmaceutics;2024-01-17

2. Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study;Multiple Sclerosis Journal;2022-06-29

3. Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022

4. Disease-modifying therapies for multiple sclerosis;BMJ;2018-11-27

5. Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade;CNS & Neurological Disorders - Drug Targets;2018-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3